These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography. Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012 [TBL] [Abstract][Full Text] [Related]
3. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Ozcan EE; Guneri S; Akdeniz B; Akyildiz IZ; Senaslan O; Baris N; Aslan O; Badak O Am Heart J; 2007 Sep; 154(3):539-44. PubMed ID: 17719303 [TBL] [Abstract][Full Text] [Related]
4. Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease. Shavit L; Korenfeld R; Lifschitz M; Butnaru A; Slotki I J Interv Cardiol; 2009 Dec; 22(6):556-63. PubMed ID: 19732281 [TBL] [Abstract][Full Text] [Related]
5. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Allaqaband S; Tumuluri R; Malik AM; Gupta A; Volkert P; Shalev Y; Bajwa TK Catheter Cardiovasc Interv; 2002 Nov; 57(3):279-83. PubMed ID: 12410497 [TBL] [Abstract][Full Text] [Related]
6. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. Chong E; Poh KK; Liang S; Soon CY; Tan HC J Interv Cardiol; 2010 Oct; 23(5):451-9. PubMed ID: 20796168 [TBL] [Abstract][Full Text] [Related]
7. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography. CalabrĂ² P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; CalabrĂ² R Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594 [TBL] [Abstract][Full Text] [Related]
8. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study. Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691 [TBL] [Abstract][Full Text] [Related]
9. Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients. van den Berk G; Tonino S; de Fijter C; Smit W; Schultz MJ Crit Care; 2005 Aug; 9(4):361-70. PubMed ID: 16137385 [TBL] [Abstract][Full Text] [Related]
10. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Masuda M; Yamada T; Mine T; Morita T; Tamaki S; Tsukamoto Y; Okuda K; Iwasaki Y; Hori M; Fukunami M Am J Cardiol; 2007 Sep; 100(5):781-6. PubMed ID: 17719320 [TBL] [Abstract][Full Text] [Related]
12. Sodium bicarbonate, N-acetylcysteine, and saline for the prevention of contrast-induced nephropathy. Bouzas-Mosquera A; Recio-Mayoral A Am Heart J; 2008 Apr; 155(4):e31. PubMed ID: 18371455 [No Abstract] [Full Text] [Related]
13. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics. Coyle LC; Rodriguez A; Jeschke RE; Simon-Lee A; Abbott KC; Taylor AJ Am Heart J; 2006 May; 151(5):1032.e9-12. PubMed ID: 16644332 [TBL] [Abstract][Full Text] [Related]
14. Prevention of contrast-induced nephropathy: a single center randomized study. Castini D; Lucreziotti S; Bosotti L; Salerno Uriarte D; Sponzilli C; Verzoni A; Lombardi F Clin Cardiol; 2010 Mar; 33(3):E63-8. PubMed ID: 20127900 [TBL] [Abstract][Full Text] [Related]
15. The third strike. Brinker JA Catheter Cardiovasc Interv; 2002 Nov; 57(3):284-5. PubMed ID: 12410498 [No Abstract] [Full Text] [Related]
16. N-acetylcysteine and/or theophylline as a preventive measure for contrast agent induced nephropathy: we should use better markers for detection of renal function. Schultz MJ Radiology; 2007 Dec; 245(3):918-9; author reply 918-9. PubMed ID: 18024462 [No Abstract] [Full Text] [Related]
17. The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions. Iyisoy A; Celik T; Yuksel UC; Bugan B; Isik E Int J Cardiol; 2009 May; 134(3):431-3; author reply 434. PubMed ID: 18501445 [TBL] [Abstract][Full Text] [Related]
18. [Nephropathy, clinical aspects and prevention]. Bahner ML Dtsch Med Wochenschr; 2006 May; 131(18):1050; author reply 1051. PubMed ID: 16673234 [No Abstract] [Full Text] [Related]
19. N-acetylcysteine versus N-acetylcysteine + theophylline for the prevention of contrast nephropathy. Baskurt M; Okcun B; Abaci O; Dogan GM; Kilickesmez K; Ozkan AA; Ersanli M; Gurmen T Eur J Clin Invest; 2009 Sep; 39(9):793-9. PubMed ID: 19500141 [TBL] [Abstract][Full Text] [Related]